Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNB01 in Moderate to Severe MDD
NCT01312922Phase 3Completed
- Sponsor
- PharmaNeuroBoost
- Start
- Sep 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pipamperone, citalopram in major depressive disorder (MDD), sponsored by PharmaNeuroBoost. Started Sep 2011; status: completed.
02
Drugs
pipamperonecitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01312922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312922.